Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $88.6 million.

  • Lifecore Biomedical's Cost of Revenue rose 8.96% to $22.5 million in Q2 2025 from the same period last year, while for May 2025 it was $88.6 million, marking a year-over-year increase of 2.50%. This contributed to the annual value of $88.6 million for FY2025, which is 2.50% up from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Cost of Revenue is $88.6 million, which was up 2.50% from $86.4 million recorded in FY2024.
  • Lifecore Biomedical's Cost of Revenue's 5-year high stood at $88.6 million during FY2025, with a 5-year trough of $61.9 million in FY2021.
  • Its 3-year average for Cost of Revenue is $83.4 million, with a median of $86.4 million in 2024.
  • In the last 5 years, Lifecore Biomedical's Cost of Revenue tumbled by 48.68% in 2021 and then grew by 16.58% in 2022.
  • Lifecore Biomedical's Cost of Revenue (Yearly) stood at $61.9 million in 2021, then rose by 16.58% to $72.2 million in 2022, then rose by 4.27% to $75.3 million in 2023, then increased by 14.78% to $86.4 million in 2024, then rose by 2.50% to $88.6 million in 2025.